Evaluation of Tofacitinib in Prevention of Photosensitivity in Lupus (ALE11)
Latest Information Update: 20 Mar 2024
At a glance
- Drugs Tofacitinib (Primary)
- Indications Cutaneous lupus erythematosus; Photosensitivity; Systemic lupus erythematosus
- Focus Proof of concept; Therapeutic Use
- Acronyms ALE11
- 15 Mar 2024 Status changed from active, no longer recruiting to completed.
- 22 Jan 2024 Planned End Date changed from 1 Dec 2023 to 4 Mar 2024.
- 22 Jan 2024 Planned primary completion date changed from 1 Dec 2023 to 19 Feb 2024.